Newly initiated insulin therapy reduces serum high sensitivity C-reactive protein concentrations in patients with type 2 diabetes

被引：0
|
作者：
Suetsugu, M
Takebayashi, K
Wakabayashi, S
Matsutomo, R
Aso, Y
Inukai, T
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A323 / A323
页数：1
相关论文
共 50 条
  • [1] Initiation of insulin therapy reduces serum concentrations of high-sensitivity C-reactive protein in patients with type 2 diabetes
    Takebayashi, K
    Aso, Y
    Inukai, T
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (06): : 693 - 699
  • [2] Obesity and serum high sensitivity C-reactive protein in Turkish immigrants with type 2 diabetes
    Sukram, Shiryn D.
    Zarini, Gustavo G.
    Huffman, Fatma G.
    FASEB JOURNAL, 2012, 26
  • [3] Serum high sensitivity C-reactive protein is not associated with microvascular complications in type 2 diabetes
    Hur, KY
    Kang, ES
    Kim, HJ
    Ahn, CW
    Cha, BS
    Lim, SK
    Lee, HC
    DIABETES, 2004, 53 : A200 - A200
  • [4] High-sensitivity C-reactive protein in Japanese patients with type 2 diabetes
    Tajiri, Y
    Mimura, K
    Umeda, F
    OBESITY RESEARCH, 2005, 13 (10): : 1810 - 1816
  • [5] Relationship between the serum concentrations of C-reactive protein and parameters of adiposity and insulin resistance in patients with type 2 diabetes mellitus
    Iwasaki, Tomoyuki
    Nakajima, Atsushi
    Yoneda, Masato
    Terauchi, Yasuo
    ENDOCRINE JOURNAL, 2006, 53 (03) : 345 - 356
  • [6] Serum high sensitivity C-reactive protein, metabolic sindrome and albuminuria in type 2 diabetes mellitus
    Canizo-Gomez, F. J.
    Moreira-Andres, M. N.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 144 - 144
  • [7] Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism
    Chu, Chih-Hsun
    Lee, Jenn-Kuen
    Wang, Mei-Chun
    Lu, Chih-Chen
    Sun, Chun-Chin
    Chuang, Ming-Ju
    Lam, Hing-Chung
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2008, 57 (10): : 1380 - 1383
  • [8] Relationship of serum high sensitivity C-reactive protein to metabolic syndrome and microvascular complications in type 2 diabetes
    Kang, ES
    Kim, HJ
    Ahn, CW
    Park, CW
    Cha, BS
    Lim, SK
    Kim, KR
    Lee, HC
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 69 (02) : 151 - 159
  • [9] Effects of Pitavastatin on Serum Lipids and High Sensitivity C-Reactive Protein in Type 2 Diabetic Patients
    Motomura, Takashi
    Okamoto, Maki
    Kitamura, Tetsuhiro
    Yamamoto, Hiroyasu
    Otsuki, Michio
    Asanuma, Nobuyuki
    Takagi, Miki
    Kurebayashi, Shogo
    Hashimoto, Kunihiko
    Sumitani, Satoru
    Saito, Hiroshi
    Kouhara, Haruhiko
    Nishii, Kazumasa
    Nakao, Makoto
    Koga, Masafumi
    Sato, Bunzo
    Morimoto, Yasuhiko
    Kasayama, Soji
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2009, 16 (05) : 546 - 552
  • [10] Association between High-Sensitivity C-Reactive Protein and Depression in Patients With Type 2 Diabetes
    Hayashino, Yasuaki
    Hataji, Yuko
    Kuwata, Hirohito
    Arai, Yusuke
    Matsunaga, Satoshi
    Okamura, Shintaro
    Mashitani, Tsuyoshi
    Furuya, Miyuki
    Kitatani, Masako
    Ikushima, Shigeki
    Tsujii, Satoru
    Ishii, Hitoshi
    DIABETES, 2013, 62 : A201 - A202
12345